Clinical Trials Browser

Withdrawn × INDUSTRY × Biliary Tract Neoplasms × Clear all

Biliary Tract Neoplasms

NCT03999658 2023-05-01

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Cholangiocarcinoma, Lymphoma, Extranodal NK-T-Cell

NCT05041972 2022-09-13

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04186156 2021-02-03

A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

Clinical Trials

A Trial of SHR1258 in Patients With Biliary Tract Cancer

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

A Study of Selective HDAC6 Inhibition With KA2507 in Advanced Biliary Tract Cancer